Skip to main content

Elopag 20 mg ( Eltrombopag)

Elopag is a brand name associated with eltrombopag, a prescription medicine used to increase platelet production in certain patients with low platelet counts. In Bangladesh, Elopag is listed as a product of Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a pharmaceutical company based in Bangladesh. Its official product catalogue includes Elopag 25 mg and Elopag 50 mg under its haematology product category.

The company develops and supplies pharmaceutical products across several therapeutic areas. Its product portfolio includes medicines for specialised treatment areas, including haematology, oncology and other medical specialties.

Important strength verification: The manufacturer’s official product catalogue currently identifies Elopag 25 mg and Elopag 50 mg. The specific Elopag 20 mg strength has not been confirmed from the official manufacturer catalogue reviewed for this page. Before publishing a claim that Everest manufactures Elopag 20 mg, verify the exact strength and manufacturer against the product packaging and official documentation.

About Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a pharmaceutical company operating in Bangladesh. The company describes its development as focused on establishing a vertically integrated pharmaceutical business.

Its official website presents information about its company profile, manufacturing facilities, product categories, quality policy and specialised pharmaceutical portfolio.

The company places emphasis on pharmaceutical manufacturing standards, technical expertise and product quality. Its stated quality policy refers to adherence to current Good Manufacturing Practice (cGMP) principles and ongoing efforts to maintain manufacturing standards.

Everest Pharmaceuticals and Elopag

Elopag is included in Everest Pharmaceuticals’ official haematology product catalogue.

The company’s listed Elopag products include:

  • Elopag 25: Eltrombopag INN 25 mg.
  • Elopag 50: Eltrombopag INN 50 mg.

Eltrombopag is the active pharmaceutical ingredient in these products. It belongs to a class of medicines known as thrombopoietin receptor agonists.

The medicine works by stimulating thrombopoietin receptors in the bone marrow, helping increase platelet production.

The inclusion of Elopag in the manufacturer’s haematology portfolio reflects its role as a specialised medicine for certain conditions involving low platelet counts.

Manufacturing and Pharmaceutical Quality

The quality of a prescription medicine depends on several factors, including the quality of its active ingredient, manufacturing processes, testing procedures, packaging and storage conditions.

Everest Pharmaceuticals describes its quality policy as emphasising cGMP practices and continuous efforts to maintain pharmaceutical manufacturing standards.

Important pharmaceutical quality considerations include:

  • Verification of raw materials.
  • Appropriate manufacturing controls.
  • Testing of finished products.
  • Packaging integrity.
  • Stability and storage requirements.
  • Compliance with applicable regulatory requirements.

Patients should obtain Elopag from a legitimate pharmacy or authorised medicine supplier. They should check the packaging, batch number, expiry date and manufacturer information before using the product.

About Eltrombopag

Eltrombopag is a thrombopoietin receptor agonist used in certain patients with thrombocytopenia, a condition characterised by an abnormally low platelet count.

Platelets are blood components that help form clots and control bleeding. When platelet levels become too low, patients may have an increased risk of bruising and bleeding.

Depending on the approved indication and local prescribing information, eltrombopag may be used for:

  • Persistent or chronic immune thrombocytopenia (ITP).
  • Thrombocytopenia associated with chronic hepatitis C in specified treatment settings.
  • Severe aplastic anaemia in approved treatment settings.

The medicine requires specialist supervision because it can cause liver toxicity, blood clots and other adverse reactions. Regular platelet-count and liver-function monitoring may be necessary.

Why Manufacturer Verification Matters

Manufacturer information is an important part of medicine identification. Different pharmaceutical companies may produce medicines containing the same active ingredient under different brand names.

Patients and healthcare professionals should distinguish between:

  • Brand name.
  • Generic or active ingredient.
  • Tablet strength.
  • Pharmaceutical formulation.
  • Manufacturing company.
  • Marketing authorisation holder.
  • Country of manufacture.
  • Local regulatory approval.

These details should be checked against the actual product label and applicable regulatory records. A company associated with one Elopag strength should not automatically be assumed to manufacture every strength or formulation sold under the same brand name in every country.

Product Identification and Verification

Before purchasing or using Elopag, check the following information on the packaging:

  1. Brand name: Elopag.
  2. Active ingredient: Eltrombopag or the labelled eltrombopag salt equivalent.
  3. Strength: Confirm the exact stated strength.
  4. Dosage form: Confirm the formulation shown on the pack.
  5. Manufacturer: Check the printed company name.
  6. Batch number: Confirm that the batch information is present.
  7. Expiry date: Ensure the medicine is within its expiry period.
  8. Regulatory information: Check the applicable registration details.

If the package states Elopag 20 mg, confirm that exact strength with the manufacturer or an authorised pharmaceutical distributor before relying on the information presented on this website.

Frequently Asked Questions About the Elopag Manufacturer

1. Who manufactures Elopag?

Everest Pharmaceuticals Ltd. is associated with the Elopag brand in Bangladesh. Its official product catalogue lists Elopag 25 mg and Elopag 50 mg.

2. Is Elopag manufactured by Everest Pharmaceuticals Ltd.?

Yes. Everest Pharmaceuticals’ official haematology catalogue identifies Elopag 25 mg and Elopag 50 mg as its products.

3. Where is Everest Pharmaceuticals based?

Everest Pharmaceuticals Ltd. is a pharmaceutical company based in Bangladesh. Its official website identifies its main manufacturing plant as being at BSCIC Kanchpur, Sonargaon, Narayanganj, Bangladesh.

4. What is the active ingredient in Elopag?

Elopag contains eltrombopag, commonly identified in pharmaceutical listings as eltrombopag or eltrombopag olamine. The exact salt-equivalent description should be checked on the product label.

5. What strengths of Elopag are listed by Everest Pharmaceuticals?

The company’s official haematology product catalogue lists Elopag 25 mg and Elopag 50 mg. Other strengths should be verified against official product documentation.

6. Does Everest Pharmaceuticals manufacture Elopag 20 mg?

The official manufacturer catalogue reviewed for this page lists Elopag 25 mg and Elopag 50 mg, but does not confirm Elopag 20 mg. The manufacturer of a 20 mg-labelled product should be checked against its packaging and official registration documents.

7. What type of medicine is Elopag?

Elopag contains eltrombopag, a thrombopoietin receptor agonist. It stimulates platelet production in the bone marrow and is prescribed for certain conditions associated with low platelet counts.

8. Is Elopag a prescription medicine?

Yes. Eltrombopag is a prescription medicine that requires medical supervision. Patients should not start, adjust or discontinue treatment without consulting their healthcare professional.

9. Does the manufacturer determine the correct Elopag dose?

The dose is determined by the treating healthcare professional according to the patient’s condition, platelet count, response to treatment and other clinical factors. It should not be selected based only on the manufacturer or tablet strength.

10. How can I verify the manufacturer of my Elopag pack?

Check the manufacturer name, product strength, batch number, expiry date and registration information printed on the original packaging. If any information is unclear, contact the manufacturer or an authorised distributor.

About This Manufacturer Information

This page provides general information about Everest Pharmaceuticals Ltd. and its association with the Elopag brand in Bangladesh. Manufacturer and product details should always be verified against official packaging and current regulatory documentation.

Product verification notice: The official Everest Pharmaceuticals catalogue reviewed for this page lists Elopag 25 mg and Elopag 50 mg. The specific Elopag 20 mg strength has not been independently verified. Do not publish an unconfirmed manufacturer attribution for that strength.